Dopamine agonist withdrawal syndrome (DAWS)
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Dopamine agonist withdrawal syndrome (DAWS). Anxiety, Panic attacks, Agoraphobia, Depression, Dysphoria, Sweating. Fully referenced neurology checklist.
Clinical features
- Anxiety
- Panic attacks
- Agoraphobia
- Depression
- Dysphoria
- Sweating
- Fatigue
- Pain
- Orthostatic hypotension
- Drug craving
- Impaired functioning
Risk factors
Locked: subscribe to see this section.
Management
Locked: subscribe to see this section.
References
- Rabinak CA, Nirenberg MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 2010; 67:58-63.
- Pondal M, Marras C, Miyasaki J, et al. Clinical features of dopamine agonist withdrawal syndrome in a movement disorder clinic. JNNP 2013; 84:130-135.
- Garcia X, Mohammad ME, Patel S, Yu XX, Fernandez HH. Dopamine agonist withdrawal syndrome associated factors: a retrospective chart review. Clin Park Relat Disord 2022; 7:100153.
